Latest news
Mankind Pharma shares fall 6% despite 30% Q1 PAT growth; here's why - Business StandardBusiness Standard · Fri, 31 Jul 2026 07:00:00 GMTMankind Pharma records over 29% YoY growth in Q1 PAT - Business StandardBusiness Standard · Thu, 30 Jul 2026 07:00:00 GMTMankind Pharma Q1 result: Profit rises 29.6% to ₹568 cr, revenue up 12.9% - Business StandardBusiness Standard · Thu, 30 Jul 2026 07:00:00 GMT